Francis LeeDirector, Tumor Pharmacology and Experimental Therapeutics Bristol-Myers Squibb
Juliet WilliamsHead of Oncology Pharmacology Novartis
Deepak SampathSenior Scientist, Translational Oncology, Genentech
Corinne ReimerAssociate Director, In Vivo Pharmacology, Oncology iMed Science Unit AstraZeneca
The 3rd Annual Tumor Models Boston is a premier networking, interactive and solution-led conference to assist pre-clinical oncologists and tumor model developers to make more clinically relevant predictions and improve the translational success of candidates into human clinical trials.
This is a meeting where attendees discover industry defining information, effective preclinical strategies and expand their network to achieve effective analysis and interpretation of data derived from tumour models.
Attend and you will:
What Next and How Do I Get Involved?
“Very valuable and useful information. One of the best meetings I’ve ever attended.” Millennium
“Very good scientific content and stimulating discussions” Metabolon
“The talks were high quality and the interaction among participants was excellent.” Genentech
“Outstanding meeting with first class speakers. I learned a lot and I will certainly recommend the meeting to my colleagues” Sanofi Aventis
“The focused meetings are very useful. It brings the right people together” Zymeworks